Cvijic Christine Mikail
SEC insider (Form 3/4/5 filer). CIK 0001543663. President and CFO at Neurogene Inc. (NGNE). 16 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in NEW YORK, NY.
Companies Cvijic Christine Mikail has filed insider reports for
- Neurogene Inc. (NGNE): Director, Officer, President and CFO
Cvijic Christine Mikail
CIK: 0001543663
Transaction Breakdown
Open Market Buys (P)1 (6.3%)
High conviction signal
Open Market Sales (S)13 (81.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (12.5%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NGNE
Neurogene Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jul 7, 2026NGNE
Neurogene Inc.
SaleDirect4.2K shares at avg. $36.13$152K - Jul 6, 2026NGNE
Neurogene Inc.
SaleDirect600 shares at avg. $36.02$22K - Jul 2, 2026NGNE
Neurogene Inc.
SaleDirect1.5K shares at avg. $35.23$54K - Jul 2, 2026NGNE
Neurogene Inc.
SaleDirect2.5K shares at avg. $34.58$88K - Jul 1, 2026NGNE
Neurogene Inc.
SaleDirect739 shares at avg. $34.06$25K - May 6, 2026NGNE
Neurogene Inc.
SaleDirect4.8K shares at avg. $30.07$144K - May 6, 2026NGNE
Neurogene Inc.
SaleDirect4.8K shares at avg. $32.44$156K - Mar 26, 2026NGNE
Neurogene Inc.
SaleDirect2.6K shares at avg. $21.62$55K - Mar 13, 2026NGNE
Neurogene Inc.
SaleDirect263 shares at avg. $22.02$6K - Mar 13, 2026NGNE
Neurogene Inc.
SaleDirect2.4K shares at avg. $20.42$49K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 | NGNE Neurogene Inc. | Sale | 4,200 | $36.13 | $151,763 | Direct |
| Jul 6, 2026 | NGNE Neurogene Inc. | Sale | 600 | $36.02 | $21,613 | Direct |
| Jul 2, 2026 | NGNE Neurogene Inc. | Sale | 1,530 | $35.23 | $53,897 | Direct |
| Jul 2, 2026 | NGNE Neurogene Inc. | Sale | 2,531 | $34.58 | $87,519 | Direct |
| Jul 1, 2026 | NGNE Neurogene Inc. | Sale | 739 | $34.06 | $25,170 | Direct |
| May 6, 2026 | NGNE Neurogene Inc. | Sale | 4,800 | $30.07 | $144,351 | Direct |
| May 6, 2026 | NGNE Neurogene Inc. | Sale | 4,800 | $32.44 | $155,692 | Direct |
| Mar 26, 2026 | NGNE Neurogene Inc. | Sale | 2,558 | $21.62 | $55,316 | Direct |
| Mar 13, 2026 | NGNE Neurogene Inc. | Sale | 263 | $22.02 | $5,791 | Direct |
| Mar 13, 2026 | NGNE Neurogene Inc. | Sale | 2,387 | $20.42 | $48,748 | Direct |
1-10 of 16 transactions